Multi-Institutional Assessment of Adverse Health Outcomes Among North American Testicular Cancer Survivors After Modern Cisplatin-Based Chemotherapy

PURPOSE: To provide new information on adverse health outcomes (AHOs) in testicular cancer survivors (TCSs) after four cycles of etoposide and cisplatin (EPX4) or three or four cycles of bleomycin, etoposide, cisplatin (BEPX3/BEPX4). METHODS: Nine hundred fifty-two TCSs > 1 year postchemotherapy...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Clin Oncol
Main Authors: Fung, Chunkit, Sesso, Howard D., Williams, Annalynn M., Kerns, Sarah L., Monahan, Patrick, Abu Zaid, Mohammad, Feldman, Darren R., Hamilton, Robert J., Vaughn, David J., Beard, Clair J., Kollmannsberger, Christian K., Cook, Ryan, Althouse, Sandra, Ardeshir-Rouhani-Fard, Shirin, Lipshultz, Steve E., Einhorn, Lawrence H., Fossa, Sophie D., Travis, Lois B.
Format: Artigo
Jezik:Inglês
Izdano: American Society of Clinical Oncology 2017
Teme:
ORIGINAL REPORTS
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5455601/
https://ncbi.nlm.nih.gov/pubmed/28240972
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2016.70.3108
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki